Confirmed objective response rate was 50% for patients treated with TTFields together with standard-of-care chemotherapy…
Data from a phase 1/2 trial in patients with several subtypes of HER3 expressing metastatic…
Confirmed objective response rate was 50% for patients treated with TTFields together with standard-of-care chemotherapy…
Data from a phase 1/2 trial in patients with several subtypes of HER3 expressing metastatic…
SUWON, South Korea--(BUSINESS WIRE)--#ClinicalTrial--OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today…
More information available at www.ProtectFujitec.com HONG KONG & TOKYO--(BUSINESS WIRE)--Oasis Management Company Ltd. (“Oasis”) is…
SYDNEY--(BUSINESS WIRE)--Lifestyle Clotheslines has launched a brand-new range of Hills Hoist clothesline products into the…
New research from Procore shows rising construction costs is the biggest and fastest growing concern…
Glamhive and Mary Kay Global Design Studio announce season two of the style competition that…
Alzheimer’s Digital Therapeutic to Unlock the Power of Music Therapy TORONTO--(BUSINESS WIRE)--12.7 million Americans aged…